Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

318
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
318
Symbiosis00:58

Symbiosis

28.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
28.2K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

334
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
334
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

244
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
244
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Comparative bioavailability of three benznidazole formulations in healthy individuals: a randomised study.

Memorias do Instituto Oswaldo Cruz·2026
Same author

Towards elimination of Chagas disease.

Bulletin of the World Health Organization·2026
Same author

From invisibility to political power: Policy lessons from a decade of Brazil's Social Forum for Infectious and Neglected Diseases.

PLoS neglected tropical diseases·2026
Same author

Prevalence and factors associated with non-vaccination: a vaccination coverage survey among children born in Ceará, Brazil, 2017-2018.

Revista da Sociedade Brasileira de Medicina Tropical·2026
Same author

Graduate studies in Collective Health in Brazil: trajectories, evaluation, and challenges.

Cadernos de saude publica·2026
Same author

Paracoccidioidomycosis in Brazil: 25-Year Nationwide Trends in Mortality, Hospitalisations and In-Hospital Deaths of a Neglected Systemic Mycosis.

Tropical medicine & international health : TM & IH·2026

Video Experimental Relacionado

Updated: Jul 8, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.3K

La enfermedad de Chagas

Andréa Silvestre de Sousa1, Debbie Vermeij2, Alberto Novaes Ramos3

  • 1Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; Department of Internal Medicine, School of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.

Lancet (London, England)
|December 10, 2023
PubMed
Resumen

La enfermedad de Chagas sigue siendo un problema de salud mundial debido a la alta carga y las rutas de transmisión emergentes. Las nuevas estrategias son vitales para el diagnóstico, el tratamiento y el control en un mundo globalizado.

Más Videos Relacionados

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

1.5K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K

Videos de Experimentos Relacionados

Last Updated: Jul 8, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
08:48

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

3.3K
Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response
07:59

Author Spotlight: Real-Time Monitoring of Parasite Burden and Host Response

Published on: May 31, 2024

1.5K
Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

15.2K

Área de la Ciencia:

  • Enfermedades tropicales desatendidas
  • Seguridad de la salud mundial
  • Epidemiología

Sus antecedentes:

  • La enfermedad de Chagas presenta un importante desafío de salud pública mundial, caracterizado por una morbilidad y mortalidad sustanciales.
  • A pesar de la disponibilidad de tratamiento y los esfuerzos de control de transmisión, los cambios epidemiológicos como la urbanización y la globalización, junto con las nuevas rutas de transmisión (orales, verticales), lo reclasifican como una enfermedad emergente.
  • Los obstáculos significativos en el diagnóstico, el tratamiento y la atención conducen a casos insuficientemente reportados, lo que dificulta el desarrollo efectivo de políticas públicas.

Objetivo del estudio:

  • Para resaltar la evolución de la enfermedad de Chagas como una amenaza emergente para la salud mundial.
  • Subrayar las limitaciones de las herramientas diagnósticas y terapéuticas actuales.
  • Abogar por la vigilancia integrada y las intervenciones políticas que aborden los determinantes sociales.

Principales métodos:

  • Revisión de las tendencias y desafíos epidemiológicos actuales en la gestión de la enfermedad de Chagas.
  • Análisis de las barreras para el diagnóstico, el tratamiento y el acceso a la atención sanitaria.
  • El énfasis en el enfoque de una sola salud y los determinantes sociales de la salud.

Principales resultados:

  • La enfermedad de Chagas se reconoce cada vez más como una enfermedad emergente debido a los cambios epidemiológicos mundiales y las nuevas vías de transmisión.
  • Las opciones de diagnóstico y tratamiento existentes presentan limitaciones, lo que restringe el acceso a la atención médica.
  • La vigilancia integrada, la participación de la comunidad y el tratamiento de los determinantes sociales son cruciales para un control eficaz.

Conclusiones:

  • La enfermedad de Chagas requiere estrategias de salud pública actualizadas debido a su naturaleza emergente y sus desafíos persistentes.
  • La validación de nuevas herramientas de diagnóstico y tratamientos es esencial para mejorar el acceso de los pacientes a la atención.
  • Un marco de salud que incorpore la participación de la comunidad y la mitigación de los determinantes sociales es fundamental para el control global de la enfermedad de Chagas.